Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuitive Surgical
ISRG
|
+$753M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$711M |
| 3 |
Humana
HUM
|
+$617M |
| 4 |
NextEra Energy
NEE
|
+$610M |
| 5 |
British American Tobacco
BTI
|
+$573M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.32B |
| 2 |
STJ
St Jude Medical
STJ
|
+$690M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$629M |
| 4 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$609M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$603M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 9.39% |
| 2 | Technology | 9.09% |
| 3 | Healthcare | 7.39% |
| 4 | Energy | 7.04% |
| 5 | Consumer Discretionary | 6.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4726
PUT
Ashland
ASH
$3.33B
| $631K | ﹤0.01% |
10,424
-6,337
| -38% | -$367K |
|
4727
CALL
Eagle Materials
EXP
$6.29B
| $631K | ﹤0.01% |
6,500
+1,700
| +35% | +$173K |
|
|
HWCC
4728
DELISTED
Houston Wire & Cable Company
HWCC
| $631K | ﹤0.01% |
93,518
+3,178
| +4% | +$21.9K |
|
4729
Babcock & Wilcox
BW
$1.39B
| $630K | ﹤0.01% |
6,745
-7,355
| -52% | -$1.03M |
|
4730
NovaGold Resources
NG
$2.56B
| $630K | ﹤0.01% |
129,396
+48,574
| +60% | +$257K |
|
|
SGEN
4731
PUT
DELISTED
Seagen Inc. Common Stock
SGEN
| $629K | ﹤0.01% |
10,000
| – | – |
|
4732
PUT
Smith & Wesson
SWBI
$651M
| $628K | ﹤0.01% |
41,242
-5,724
| -12% | -$87.3K |
|
|
EEP
4733
PUT
DELISTED
Enbridge Energy Partners
EEP
| $627K | ﹤0.01% |
33,000
+8,500
| +35% | +$172K |
|
4734
PUT
D.R. Horton
DHI
$40B
| $626K | ﹤0.01% |
18,800
-61,200
| -77% | -$1.9M |
|
4735
VanEck Short High Yield Muni ETF
SHYD
$451M
| $626K | ﹤0.01% |
+26,086
| New | +$624K |
|
4736
iShares Future Exponential Technologies ETF
XT
$3.82B
| $626K | ﹤0.01% |
21,076
+13,470
| +177% | +$385K |
|
|
XINA
4737
DELISTED
SPDR MSCI China A Shares IMI ETF
XINA
| $626K | ﹤0.01% |
29,050
-100
| -0.3% | -$2.17K |
|
4738
Pacific Biosciences
PACB
$435M
| $625K | ﹤0.01% |
120,863
-120,046
| -50% | -$588K |
|
4739
CALL
Chemours
CC
$2.5B
| $624K | ﹤0.01% |
16,200
-10,840
| -40% | -$326K |
|
|
PPL
4740
PUT
PPL Corp
PPL
$26.5B
| $624K | ﹤0.01% |
16,700
-10,100
| -38% | -$361K |
|
4741
TransAlta
TAC
$3.95B
| $623K | ﹤0.01% |
106,435
+50,235
| +89% | +$285K |
|
|
QADA
4742
DELISTED
QAD Inc.
QADA
| $623K | ﹤0.01% |
22,344
+11,760
| +111% | +$339K |
|
4743
iShares US Consumer Discretionary ETF
IYC
$1.17B
| $622K | ﹤0.01% |
15,452
+8
| +0.1% | +$315 |
|
4744
PUT
Nokia
NOK
$51B
| $622K | ﹤0.01% |
114,700
-3,000
| -3% | -$15.1K |
|
|
BMTC
4745
DELISTED
Bryn Mawr Bank Corp
BMTC
| $622K | ﹤0.01% |
15,754
-7,344
| -32% | -$297K |
|
4746
Alpha and Omega Semiconductor
AOSL
$950M
| $620K | ﹤0.01% |
36,059
+551
| +2% | +$10.9K |
|
4747
PUT
Monster Beverage
MNST
$94.3B
| $619K | ﹤0.01% |
26,800
-20,200
| -43% | -$451K |
|
4748
PUT
Barclays
BCS
$92.7B
| $615K | ﹤0.01% |
57,500
-80,665
| -58% | -$867K |
|
4749
CALL
Groupon
GRPN
$1.05B
| $615K | ﹤0.01% |
7,825
-960
| -11% | -$74K |
|
4750
Matinas BioPharma
MTNB
$1.88M
| $614K | ﹤0.01% |
+4,434
| New | +$723K |
|
Similar funds
Goldman Sachs's Q1 2017 Portfolio in Review
As of Q1 2017, Goldman Sachs held 7,322 positions worth $369B, up 4.2% from $354B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Goldman Sachs's Q1 2017 filing shows 455 new, 2,594 increased, 3,387 reduced and 597 closed positions. Its largest new stake was Deutsche Bank Aktiengesellschaft: 36,861,723 shares worth $87M. The largest sale was NVIDIA, an estimated $1.32B.
By sector, the portfolio is most concentrated in Financials at 9.4% of assets, down from 9.9% a quarter earlier, followed by Technology and Healthcare.
- Goldman Sachs's largest Q1 2017 buy was Deutsche Bank Aktiengesellschaft: 36,861,723 shares worth $87M.
- Goldman Sachs added most to Intuitive Surgical in Q1 2017, an estimated $753M increase.
- Goldman Sachs's biggest Q1 2017 reduction was NVIDIA, cutting an estimated $1.32B.
- Goldman Sachs fully exited St Jude Medical in Q1 2017, selling an estimated $690M.
- Goldman Sachs's ten largest holdings make up 16% of its $369B portfolio in Q1 2017.
- Goldman Sachs opened 455 new positions and closed 597 in Q1 2017.
- Goldman Sachs's portfolio value rose 4.2% quarter-over-quarter to $369B.
Based on Goldman Sachs's 13F filing for Q1 2017, filed 15 May 2017.